BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Böttner M, Fricke T, Müller M, Barrenschee M, Deuschl G, Schneider SA, Egberts J, Becker T, Fritscher-ravens A, Ellrichmann M, Schulz-schaeffer WJ, Wedel T. Alpha-synuclein is associated with the synaptic vesicle apparatus in the human and rat enteric nervous system. Brain Research 2015;1614:51-9. [DOI: 10.1016/j.brainres.2015.04.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Swaminathan M, Fung C, Finkelstein DI, Bornstein JC, Foong JPP. α-Synuclein Regulates Development and Function of Cholinergic Enteric Neurons in the Mouse Colon. Neuroscience 2019;423:76-85. [PMID: 31705886 DOI: 10.1016/j.neuroscience.2019.10.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Vidović M, Rikalovic MG. Alpha-Synuclein Aggregation Pathway in Parkinson's Disease: Current Status and Novel Therapeutic Approaches. Cells 2022;11:1732. [PMID: 35681426 DOI: 10.3390/cells11111732] [Reference Citation Analysis]
3 Ip CW, Klaus LC, Karikari AA, Visanji NP, Brotchie JM, Lang AE, Volkmann J, Koprich JB. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease. Acta Neuropathol Commun 2017;5:11. [PMID: 28143577 DOI: 10.1186/s40478-017-0416-x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 12.8] [Reference Citation Analysis]
4 Schaeffer E, Kluge A, Böttner M, Zunke F, Cossais F, Berg D, Arnold P. Alpha Synuclein Connects the Gut-Brain Axis in Parkinson's Disease Patients - A View on Clinical Aspects, Cellular Pathology and Analytical Methodology. Front Cell Dev Biol 2020;8:573696. [PMID: 33015066 DOI: 10.3389/fcell.2020.573696] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
5 Longhena F, Faustini G, Missale C, Pizzi M, Spano P, Bellucci A. The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy. Neural Plast 2017;2017:5012129. [PMID: 28133550 DOI: 10.1155/2017/5012129] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 8.6] [Reference Citation Analysis]
6 Shannon K, Vanden Berghe P. The enteric nervous system in PD: gateway, bystander victim, or source of solutions. Cell Tissue Res 2018;373:313-26. [PMID: 29936550 DOI: 10.1007/s00441-018-2856-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
7 Mei JM, Niu CS. How does conserved dopamine neurotrophic factor protect against and rescue neurodegeneration of PC12 cells? Neural Regen Res 2017;12:1145-51. [PMID: 28852398 DOI: 10.4103/1673-5374.211195] [Reference Citation Analysis]
8 Kleinknecht A, Popova B, Lázaro DF, Pinho R, Valerius O, Outeiro TF, Braus GH. C-Terminal Tyrosine Residue Modifications Modulate the Protective Phosphorylation of Serine 129 of α-Synuclein in a Yeast Model of Parkinson's Disease. PLoS Genet 2016;12:e1006098. [PMID: 27341336 DOI: 10.1371/journal.pgen.1006098] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
9 Stokholm MG, Danielsen EH, Hamilton-dutoit SJ, Borghammer P. Pathological α-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients: α-Synuclein in Prodromal PD. Ann Neurol 2016;79:940-9. [DOI: 10.1002/ana.24648] [Cited by in Crossref: 170] [Cited by in F6Publishing: 159] [Article Influence: 28.3] [Reference Citation Analysis]
10 Preterre C, Corbillé AG, Balloy G, Letournel F, Neunlist M, Derkinderen P. Optimizing Western Blots for the Detection of Endogenous α-Synuclein in the Enteric Nervous System. J Parkinsons Dis 2015;5:765-72. [PMID: 26599299 DOI: 10.3233/JPD-150670] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
11 Lee W, Koh S, Hwang S, Kim SH. Presynaptic Dysfunction by Familial Factors in Parkinson Disease. Int Neurourol J 2018;22:S115-121. [PMID: 30396260 DOI: 10.5213/inj.1836216.108] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Naskar A, Mahadevan A, Philip M, Alladi PA. Aging mildly affects dendritic arborisation and synaptic protein expression in human substantia nigra pars compacta. Journal of Chemical Neuroanatomy 2019;97:57-65. [DOI: 10.1016/j.jchemneu.2019.02.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Derkinderen P, Rolli-Derkinderen M, Chapelet G, Neunlist M, Noble W. Tau in the gut, does it really matter? J Neurochem 2021;158:94-104. [PMID: 33569813 DOI: 10.1111/jnc.15320] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Magistrelli L, Comi C. Beta2-Adrenoceptor Agonists in Parkinson’s Disease and Other Synucleinopathies. J Neuroimmune Pharmacol 2020;15:74-81. [DOI: 10.1007/s11481-018-09831-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]